YD Bio YDES
NASDAQ YDES
$6.19 -0.99 (-13.79%)
At close: Nov 6, 2026 · 4:00 PM EST

YD Bio (YDES) Receivables (2024 - 2026)

Updated

YD Bio (YDES) reported Receivables of $480,971 for the quarter ended Jun 30, 2026, up 757.1% from $56,114 a year earlier.

Analysis

YD Bio (YDES) Receivables (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio posted Receivables of $459,017, up 343.5% from the prior year.

  • By year, Receivables came in at $103,509 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 18.99 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 13.51 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 16.16 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 14.19 Bn
10 YD Bio 397.65 Mn 385.37 Mn - 223,067.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223,067.00
Dec 31, 2025 459,017.00
Jun 30, 2025 101,430.00
Dec 31, 2024 103,509.00
API Access

YD Bio Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=YDES&period=max&api_key=YOUR_API_KEY